[go: up one dir, main page]

ITMI950532A0 - Derivato di aminotetralina per la terapia di malattie cardiovascolari - Google Patents

Derivato di aminotetralina per la terapia di malattie cardiovascolari

Info

Publication number
ITMI950532A0
ITMI950532A0 ITMI950532A ITMI950532A ITMI950532A0 IT MI950532 A0 ITMI950532 A0 IT MI950532A0 IT MI950532 A ITMI950532 A IT MI950532A IT MI950532 A ITMI950532 A IT MI950532A IT MI950532 A0 ITMI950532 A0 IT MI950532A0
Authority
IT
Italy
Prior art keywords
therapy
cardiovascular diseases
aminotetralin derivative
aminotetralin
derivative
Prior art date
Application number
ITMI950532A
Other languages
English (en)
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razzetti
Maurizio Civelli
Alberto Umile
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI950532A0 publication Critical patent/ITMI950532A0/it
Priority to IT95MI000532A priority Critical patent/IT1275935B1/it
Priority to SK1254-97A priority patent/SK282952B6/sk
Priority to NZ303993A priority patent/NZ303993A/xx
Priority to AU51072/96A priority patent/AU702656B2/en
Priority to CN96193312A priority patent/CN1112920C/zh
Priority to KR1019970706438A priority patent/KR100391143B1/ko
Priority to PL96322284A priority patent/PL183347B1/pl
Priority to ES96907446T priority patent/ES2177769T3/es
Priority to PCT/EP1996/001060 priority patent/WO1996029065A2/en
Priority to HK98104093.1A priority patent/HK1004802B/en
Priority to JP8528045A priority patent/JPH11502211A/ja
Priority to EE9700231A priority patent/EE04040B1/xx
Priority to PT96907446T priority patent/PT814791E/pt
Priority to EP96907446A priority patent/EP0814791B1/en
Priority to DE69621786T priority patent/DE69621786T2/de
Priority to EA199700243A priority patent/EA000937B1/ru
Priority to HU9801686A priority patent/HUP9801686A3/hu
Priority to US08/913,363 priority patent/US6013678A/en
Priority to BR9607996A priority patent/BR9607996A/pt
Priority to SI9620036A priority patent/SI9620036B/sl
Priority to TR97/00963T priority patent/TR199700963T1/xx
Priority to DK96907446T priority patent/DK0814791T3/da
Priority to AT96907446T priority patent/ATE218856T1/de
Priority to EP02001772A priority patent/EP1216702A3/en
Priority to CZ19972866A priority patent/CZ288488B6/cs
Priority to CA002215671A priority patent/CA2215671A1/en
Priority to MX9706971A priority patent/MX9706971A/es
Priority to ZA962073A priority patent/ZA962073B/xx
Priority to IL11751896A priority patent/IL117518A/en
Publication of ITMI950532A1 publication Critical patent/ITMI950532A1/it
Priority to LT97-147A priority patent/LT4355B/lt
Priority to LVP-97-166A priority patent/LV11882B/en
Priority to NO19974267A priority patent/NO317402B1/no
Application granted granted Critical
Publication of IT1275935B1 publication Critical patent/IT1275935B1/it
Priority to US09/328,434 priority patent/US6103760A/en
Priority to IL13541600A priority patent/IL135416A0/xx
Priority to HK02109206.9A priority patent/HK1048060A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT95MI000532A 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari IT1275935B1 (it)

Priority Applications (35)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
BR9607996A BR9607996A (pt) 1995-03-17 1996-03-13 Derivado de aminotetralina para o tratamento de doenças cardiovasculares
SI9620036A SI9620036B (sl) 1995-03-17 1996-03-13 Derivat aminotetralina za terapijo kardiovaskularnih bolezni
AU51072/96A AU702656B2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
CN96193312A CN1112920C (zh) 1995-03-17 1996-03-13 氨基四氢化萘衍生物在制备治疗心脏病的药物中用途
KR1019970706438A KR100391143B1 (ko) 1995-03-17 1996-03-13 심장혈관계질병치료용아미노테트랄린화합물
DK96907446T DK0814791T3 (da) 1995-03-17 1996-03-13 Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
ES96907446T ES2177769T3 (es) 1995-03-17 1996-03-13 Derivado de aminotetralina para la terapia de trastornos cardiovascu lares.
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
HK98104093.1A HK1004802B (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
JP8528045A JPH11502211A (ja) 1995-03-17 1996-03-13 心血管系疾患の治療のためのアミノテトラリン誘導体
EE9700231A EE04040B1 (et) 1995-03-17 1996-03-13 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
PT96907446T PT814791E (pt) 1995-03-17 1996-03-13 Derivado de aminotetralina para a terapia de doencas cardiovasculares
EP96907446A EP0814791B1 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
DE69621786T DE69621786T2 (de) 1995-03-17 1996-03-13 Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EA199700243A EA000937B1 (ru) 1995-03-17 1996-03-13 Применение производных аминотетралина для лечения застойной сердечной недостаточности
HU9801686A HUP9801686A3 (en) 1995-03-17 1996-03-13 Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases
US08/913,363 US6013678A (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
SK1254-97A SK282952B6 (sk) 1995-03-17 1996-03-13 Farmaceutický prostriedok s obsahom 5,6-diizobutyroyloxy-2- metylaminotetralínu a jeho použitie
TR97/00963T TR199700963T1 (xx) 1995-03-17 1996-03-13 Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
NZ303993A NZ303993A (en) 1995-03-17 1996-03-13 Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
PL96322284A PL183347B1 (pl) 1995-03-17 1996-03-13 Zastosowanie 5,6-diizobutyroiloksy-2-metyloaminotetraliny i 5,6-dihydroksy-2-metyloaminotetraliny
AT96907446T ATE218856T1 (de) 1995-03-17 1996-03-13 Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EP02001772A EP1216702A3 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
CZ19972866A CZ288488B6 (en) 1995-03-17 1996-03-13 Pharmaceutical preparation for treating cardiovascular diseases
CA002215671A CA2215671A1 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases
MX9706971A MX9706971A (es) 1995-03-17 1996-03-13 Derivado de aminotetralina para la terapia de las enfermedades cardiovasculares.
ZA962073A ZA962073B (en) 1995-03-17 1996-03-14 Aminotetralin derivative for the therapy of cardiovascular diseases
IL11751896A IL117518A (en) 1995-03-17 1996-03-17 The use of the product of aminotterlin to prepare a drug for the treatment of cardiovascular disease
LT97-147A LT4355B (lt) 1995-03-17 1997-09-15 Aminotetralino darinys širdies ir kraujagyslių susirgimų gydymui
LVP-97-166A LV11882B (en) 1995-03-17 1997-09-15 AMINOTETRALINE DERIVATIVES FOR TREATMENT OF CIRCULAR AND HUMAN DISEASES
NO19974267A NO317402B1 (no) 1995-03-17 1997-09-16 Anvendelse av aminotetralinderivat eller et farmasoytisk akseptabelt salt derav og farmasoytiske sammensetninger inneholdende det samme ved behandling av kongestiv hjertesvikt
US09/328,434 US6103760A (en) 1995-03-17 1999-06-09 Aminotetralin derivative for the therapy of cardiovascular diseases
IL13541600A IL135416A0 (en) 1995-03-17 2000-04-02 The use of an aminotetralin derivative in the preparation of pharmaceutical compositions for the treatment of cardiovascular diseases
HK02109206.9A HK1048060A1 (en) 1995-03-17 2002-12-19 Amino 1,2,3,4-tetralin derivatives for the treatment of cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari

Publications (3)

Publication Number Publication Date
ITMI950532A0 true ITMI950532A0 (it) 1995-03-17
ITMI950532A1 ITMI950532A1 (it) 1996-09-17
IT1275935B1 IT1275935B1 (it) 1997-10-24

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari

Country Status (31)

Country Link
US (2) US6013678A (it)
EP (2) EP0814791B1 (it)
JP (1) JPH11502211A (it)
KR (1) KR100391143B1 (it)
CN (1) CN1112920C (it)
AT (1) ATE218856T1 (it)
AU (1) AU702656B2 (it)
BR (1) BR9607996A (it)
CA (1) CA2215671A1 (it)
CZ (1) CZ288488B6 (it)
DE (1) DE69621786T2 (it)
DK (1) DK0814791T3 (it)
EA (1) EA000937B1 (it)
EE (1) EE04040B1 (it)
ES (1) ES2177769T3 (it)
HK (1) HK1048060A1 (it)
HU (1) HUP9801686A3 (it)
IL (1) IL117518A (it)
IT (1) IT1275935B1 (it)
LT (1) LT4355B (it)
LV (1) LV11882B (it)
MX (1) MX9706971A (it)
NO (1) NO317402B1 (it)
NZ (1) NZ303993A (it)
PL (1) PL183347B1 (it)
PT (1) PT814791E (it)
SI (1) SI9620036B (it)
SK (1) SK282952B6 (it)
TR (1) TR199700963T1 (it)
WO (1) WO1996029065A2 (it)
ZA (1) ZA962073B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
ES2206240T3 (es) * 1999-06-09 2004-05-16 Chiesi Farmaceutici S.P.A. Derivados de aminotetralina para el tratamiento de trastornnos cardiovasculares.
EP1331004A3 (en) * 1999-06-09 2003-08-06 CHIESI FARMACEUTICI S.p.A. Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
US6013678A (en) 2000-01-11
DE69621786D1 (de) 2002-07-18
ES2177769T3 (es) 2002-12-16
NO974267D0 (no) 1997-09-16
EE04040B1 (et) 2003-06-16
PT814791E (pt) 2002-10-31
IL117518A (en) 2001-05-20
LT4355B (lt) 1998-06-25
EP0814791B1 (en) 2002-06-12
CA2215671A1 (en) 1996-09-26
CZ286697A3 (cs) 1998-03-18
EP1216702A2 (en) 2002-06-26
EP0814791A1 (en) 1998-01-07
LV11882A (lv) 1997-12-20
LT97147A (en) 1998-02-25
WO1996029065A2 (en) 1996-09-26
KR19980703030A (ko) 1998-09-05
NO317402B1 (no) 2004-10-25
HK1004802A1 (en) 1998-12-11
JPH11502211A (ja) 1999-02-23
HUP9801686A2 (hu) 1999-06-28
DK0814791T3 (da) 2002-10-07
CN1181699A (zh) 1998-05-13
CZ288488B6 (en) 2001-06-13
CN1112920C (zh) 2003-07-02
IL117518A0 (en) 1996-07-23
LV11882B (en) 1998-03-20
AU5107296A (en) 1996-10-08
WO1996029065A3 (en) 1996-11-28
EE9700231A (et) 1998-04-15
ITMI950532A1 (it) 1996-09-17
SI9620036A (sl) 1998-02-28
US6103760A (en) 2000-08-15
SK125497A3 (en) 1998-02-04
SI9620036B (sl) 2002-10-31
PL322284A1 (en) 1998-01-19
ZA962073B (en) 1996-11-27
PL183347B1 (pl) 2002-06-28
NZ303993A (en) 2000-12-22
IT1275935B1 (it) 1997-10-24
EP1216702A3 (en) 2002-09-04
TR199700963T1 (xx) 1998-02-21
NO974267L (no) 1997-11-07
AU702656B2 (en) 1999-02-25
MX9706971A (es) 1997-11-29
HUP9801686A3 (en) 1999-10-28
KR100391143B1 (ko) 2003-11-28
EA000937B1 (ru) 2000-06-26
EA199700243A1 (ru) 1998-02-26
ATE218856T1 (de) 2002-06-15
HK1048060A1 (en) 2003-03-21
DE69621786T2 (de) 2003-01-02
SK282952B6 (sk) 2003-01-09
BR9607996A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
NO973612L (no) Nytt farmasöytisk preparat
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
FI956227L (fi) Sisäänhengitykseen tarkoitettu terapeuttinen valmiste
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
IT1276799B1 (it) Formulazioni di f-silicone
ITMI950532A0 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO973610D0 (no) Nytt farmasöytisk preparat
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
EP0790062A4 (en) REMEDY FOR HEART DISEASE
NO973611D0 (no) Nytt farmasöytisk preparat
DE59610423D1 (de) Partikulare arzneiform
ITMI951629A0 (it) Manichino per la simulazione di patologie cardiache
IT1290151B1 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
ITTV950068V0 (it) Struttura di calzatura particolarmente per pattini
ITMI951630A0 (it) Manichino per la simulazione di patologie cardiache
NO962385D0 (no) Terapeutiske amider
KR970020845U (ko) 근골격계질환 치료보조용 테이프
IT1281441B1 (it) Procedimento per la fabbricazione di scarpe
KR970004684U (ko) 쇼케이스의 캐스터 고정구조
KR970026645U (ko) 축구화의 실축조정이 가능한 축구화

Legal Events

Date Code Title Description
0001 Granted